mAb Development

Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 08, 2018
By BioPharm International Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Feb 14, 2018
By BioPharm International Editors
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
Feb 01, 2018
BioPharm International
Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
Jan 31, 2018
By BioPharm International Editors
The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.
Jan 23, 2018
By BioPharm International Editors
The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.
Jan 12, 2018
By BioPharm International Editors
An antibody-based Zika virus therapeutic that protected monkeys from infection might be safe enough for administration to pregnant women.
Jan 12, 2018
By BioPharm International Editors
A new target for the treatment of multiple myeloma using CAR-T technology was discovered by researchers at Osaka University.
Jan 11, 2018
By BioPharm International Editors
Sartorius Stedim Biotech will equip Abzena’s contract development and manufacturing facilities in Bristol, PA, and San Diego, CA, with single-use equipment and scale-up technologies.
Jan 04, 2018
By BioPharm International Editors
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
native1_300x100
lorem ipsum